A detailed history of Bruderman Asset Management, LLC transactions in Organon & Co. stock. As of the latest transaction made, Bruderman Asset Management, LLC holds 17,570 shares of OGN stock, worth $258,806. This represents 1.06% of its overall portfolio holdings.

Number of Shares
17,570
Previous 18,431 4.67%
Holding current value
$258,806
Previous $643,000 7.78%
% of portfolio
1.06%
Previous 0.97%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$31.66 - $38.9 $27,259 - $33,492
-861 Reduced 4.67%
17,570 $593,000
Q1 2022

May 13, 2022

SELL
$30.45 - $39.36 $503,673 - $651,053
-16,541 Reduced 47.3%
18,431 $643,000
Q4 2021

Feb 14, 2022

SELL
$28.67 - $37.13 $1.51 Million - $1.95 Million
-52,614 Reduced 60.07%
34,972 $1.07 Million
Q3 2021

Oct 13, 2021

BUY
$28.63 - $35.64 $2.51 Million - $3.12 Million
87,586 New
87,586 $2.87 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Bruderman Asset Management, LLC Portfolio

Follow Bruderman Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruderman Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bruderman Asset Management, LLC with notifications on news.